Legend Biotech Non-GAAP EPS of $0.01 misses by $0.18, revenue of $306.3M misses by $3.91M
Source: SeekingAlpha
2026-03-10 07:03:24 ET
More on Legend Biotech
- Legend Biotech: Carvykti Driving Growth Amid FDA Regulatory Tailwinds
- Legend Biotech Corporation (LEGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Legend Biotech Q4 2025 Earnings Preview
- Legend Biotech Arcellx rise after FDA draft guidance on multiple myeloma trials
- Seeking Alpha’s Quant Rating on Legend Biotech
Read the full article on Seeking Alpha
For further details see:
Legend Biotech Non-GAAP EPS of $0.01 misses by $0.18, revenue of $306.3M misses by $3.91M
Legend Biotech Corporation
NASDAQ: LEGN
LEGN Trading
38.04% G/L:
$34.62 Last:
9,783,080 Volume:
$25.37 Open:
LEGN Latest News
June 02, 2026 09:30:00 am
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
LEGN Stock Data
$3,309,357,827
166,569,786
N/A
63
N/A
Biotechnology & Life Sciences
Healthcare
US
Somerset
